130 related articles for article (PubMed ID: 21110316)
1. Treg and T-effector cells in autoimmune CNS inflammation: a delicate balance, easily disturbed.
Anderton SM
Eur J Immunol; 2010 Dec; 40(12):3321-4. PubMed ID: 21110316
[TBL] [Abstract][Full Text] [Related]
2. Reduced Treg frequency in LFA-1-deficient mice allows enhanced T effector differentiation and pathology in EAE.
Gültner S; Kuhlmann T; Hesse A; Weber JP; Riemer C; Baier M; Hutloff A
Eur J Immunol; 2010 Dec; 40(12):3403-12. PubMed ID: 21108463
[TBL] [Abstract][Full Text] [Related]
3. LFA-1 Controls Th1 and Th17 Motility Behavior in the Inflamed Central Nervous System.
Dusi S; Angiari S; Pietronigro EC; Lopez N; Angelini G; Zenaro E; Della Bianca V; Tosadori G; Paris F; Amoruso A; Carlucci T; Constantin G; Rossi B
Front Immunol; 2019; 10():2436. PubMed ID: 31681316
[TBL] [Abstract][Full Text] [Related]
4. Defects in CD4+ T cell LFA-1 integrin-dependent adhesion and proliferation protect Cd47-/- mice from EAE.
Azcutia V; Bassil R; Herter JM; Engelbertsen D; Newton G; Autio A; Mayadas T; Lichtman AH; Khoury SJ; Parkos CA; Elyaman W; Luscinskas FW
J Leukoc Biol; 2017 Feb; 101(2):493-505. PubMed ID: 27965383
[TBL] [Abstract][Full Text] [Related]
5. Effector and suppressor roles for LFA-1 during the development of experimental autoimmune encephalomyelitis.
Dugger KJ; Zinn KR; Weaver C; Bullard DC; Barnum SR
J Neuroimmunol; 2009 Jan; 206(1-2):22-7. PubMed ID: 19010554
[TBL] [Abstract][Full Text] [Related]
6. Integrin alpha L controls the homing of regulatory T cells during CNS autoimmunity in the absence of integrin alpha 4.
Glatigny S; Duhen R; Arbelaez C; Kumari S; Bettelli E
Sci Rep; 2015 Jan; 5():7834. PubMed ID: 25592296
[TBL] [Abstract][Full Text] [Related]
7. CCR6 regulates EAE pathogenesis by controlling regulatory CD4+ T-cell recruitment to target tissues.
Villares R; Cadenas V; Lozano M; Almonacid L; Zaballos A; Martínez-A C; Varona R
Eur J Immunol; 2009 Jun; 39(6):1671-81. PubMed ID: 19499521
[TBL] [Abstract][Full Text] [Related]
8. Lack of adiponectin leads to increased lymphocyte activation and increased disease severity in a mouse model of multiple sclerosis.
Piccio L; Cantoni C; Henderson JG; Hawiger D; Ramsbottom M; Mikesell R; Ryu J; Hsieh CS; Cremasco V; Haynes W; Dong LQ; Chan L; Galimberti D; Cross AH
Eur J Immunol; 2013 Aug; 43(8):2089-100. PubMed ID: 23640763
[TBL] [Abstract][Full Text] [Related]
9. Self-antigen-driven activation induces instability of regulatory T cells during an inflammatory autoimmune response.
Bailey-Bucktrout SL; Martinez-Llordella M; Zhou X; Anthony B; Rosenthal W; Luche H; Fehling HJ; Bluestone JA
Immunity; 2013 Nov; 39(5):949-62. PubMed ID: 24238343
[TBL] [Abstract][Full Text] [Related]
10. CD226 Attenuates Treg Proliferation via Akt and Erk Signaling in an EAE Model.
Wang N; Yi H; Fang L; Jin J; Ma Q; Shen Y; Li J; Liang S; Xiong J; Li Z; Zeng H; Jiang F; Jin B; Chen L
Front Immunol; 2020; 11():1883. PubMed ID: 32983109
[TBL] [Abstract][Full Text] [Related]
11. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.
Rostami A; Ciric B
J Neurol Sci; 2013 Oct; 333(1-2):76-87. PubMed ID: 23578791
[TBL] [Abstract][Full Text] [Related]
12. Swift entry of myelin-specific T lymphocytes into the central nervous system in spontaneous autoimmune encephalomyelitis.
Furtado GC; Marcondes MC; Latkowski JA; Tsai J; Wensky A; Lafaille JJ
J Immunol; 2008 Oct; 181(7):4648-55. PubMed ID: 18802067
[TBL] [Abstract][Full Text] [Related]
13. Endogenous T Cell Receptor Rearrangement Represses Aggressive Central Nervous System Autoimmunity in a TcR-Transgenic Model on the Non-Obese Diabetic Background.
Yeola AP; Ignatius Arokia Doss PM; Baillargeon J; Akbar I; Mailhot B; Balood M; Talbot S; Anderson AC; Lacroix S; Rangachari M
Front Immunol; 2019; 10():3115. PubMed ID: 32010149
[TBL] [Abstract][Full Text] [Related]
14. MHC-mismatched mixed chimerism augments thymic regulatory T-cell production and prevents relapse of EAE in mice.
Wu L; Li N; Zhang M; Xue SL; Cassady K; Lin Q; Riggs AD; Zeng D
Proc Natl Acad Sci U S A; 2015 Dec; 112(52):15994-9. PubMed ID: 26647186
[TBL] [Abstract][Full Text] [Related]
15. Antigen-specific splenic CD4+ and CD8+ regulatory T cells generated via the eye, suppress experimental autoimmune encephalomyelitis either at the priming or at the effector phase.
Bhowmick S; Clark RB; Brocke S; Cone RE
Int Immunol; 2011 Feb; 23(2):119-28. PubMed ID: 21273399
[TBL] [Abstract][Full Text] [Related]
16. Chloroquine treatment enhances regulatory T cells and reduces the severity of experimental autoimmune encephalomyelitis.
Thomé R; Moraes AS; Bombeiro AL; Farias Ados S; Francelin C; da Costa TA; Di Gangi R; dos Santos LM; de Oliveira AL; Verinaud L
PLoS One; 2013; 8(6):e65913. PubMed ID: 23799062
[TBL] [Abstract][Full Text] [Related]
17. Cyclic AMP Pathway Suppress Autoimmune Neuroinflammation by Inhibiting Functions of Encephalitogenic CD4 T Cells and Enhancing M2 Macrophage Polarization at the Site of Inflammation.
Veremeyko T; Yung AWY; Dukhinova M; Kuznetsova IS; Pomytkin I; Lyundup A; Strekalova T; Barteneva NS; Ponomarev ED
Front Immunol; 2018; 9():50. PubMed ID: 29422898
[TBL] [Abstract][Full Text] [Related]
18. B cell regulation of CD4+CD25+ T regulatory cells and IL-10 via B7 is essential for recovery from experimental autoimmune encephalomyelitis.
Mann MK; Maresz K; Shriver LP; Tan Y; Dittel BN
J Immunol; 2007 Mar; 178(6):3447-56. PubMed ID: 17339439
[TBL] [Abstract][Full Text] [Related]
19. Melatonin controls experimental autoimmune encephalomyelitis by altering the T effector/regulatory balance.
Álvarez-Sánchez N; Cruz-Chamorro I; López-González A; Utrilla JC; Fernández-Santos JM; Martínez-López A; Lardone PJ; Guerrero JM; Carrillo-Vico A
Brain Behav Immun; 2015 Nov; 50():101-114. PubMed ID: 26130320
[TBL] [Abstract][Full Text] [Related]
20. Primaquine elicits Foxp3
Thome R; Casella G; Lotfi N; Ishikawa LWL; Wang Q; Ciric B; Zhang GX; Rostami A
J Autoimmun; 2020 Nov; 114():102505. PubMed ID: 32595012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
